ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Clever Carnivore Opens New Chicago Headquarters and Lab

Cultivated meat startup is ready to meet this moment

What if we could make meat … better? A new company in Chicago is now producing actual meat with science — not slaughter — using breakthroughs in stem cell biology.

Paul Burridge, Ph.D., a Northwestern University associate professor of pharmacology, and a growing team of scientists have recently formed a new company called Clever Carnivore. They’re fast-tracking meat-making biotechnology and already expanding their business with a new headquarters and lab.

The new 4,179-square-foot facility at 2430 North Halsted St. in Chicago’s Lincoln Park neighborhood puts Clever Carnivore near Chicago’s academic epicenter.

Time is of the essence

Food insecurity and food prices are steadily rising in the U.S. and around the world, a condition made worse in recent years by the COVID-19 pandemic. The cost and complexities of factory farming are growing exponentially, compounded by environmental and ethical issues.

“We have both the opportunity and the obligation to tackle this problem right now,” said Burridge, Clever Carnivore’s founder and chief scientific officer. “We can produce healthier, drug-free and cruelty-free meat from live cells without harm. At the same time, we can dramatically reduce greenhouse gas emissions from manufacturing and processing.”

Importantly, Clever Carnivore is not producing meat alternatives. It’s making actual pork, beef and chicken using stem cell biology, recombinant protein technology and bioengineering. The cultivated meat is identical, cell for cell, to the chops, steaks and wings found today in your grocer’s meat department.

One major difference is the elimination of pathogens such as salmonella and E. coli — and the welcome absence of antibiotics, steroids, disinfectants, pesticides and nitrates.

Cultivated meat is nutritionally equal to traditional meat. Its menu applications — from high-end cuisine to backyard barbecues — are entirely the same.

Costs for lab-grown meat products are currently higher than those of their conventional counterparts, but with increased volumes, production costs will ultimately be lower than those of factory farming. Clever Carnivore is uniquely positioned to streamline and scale up the cultivated meat production process due to the team’s background in low-cost cell culture media optimization.

Science means business

Cultivated meat is an early-stage industry, but the science itself is well established. “This is yet another demonstration of the potential of stem cell biology to solve complex human and societal challenges,” added Burridge.

Clever Carnivore’s team of leading scientists also includes Davi Lyra-Leite, a biomedical engineer with expertise in stem cells, metabolism and differentiation; Phillip Freeman, a chemist and bioprocess engineer with expertise in gene therapy manufacturing; Ray Copley, a biomedical scientist, engineer and former aerospace research analyst; and Donny McKenna, a developmental biologist with expertise in biochemical research and drug discovery.

Clever Carnivore raised $2.1 million in pre-seed funding from private investors. Prospective investors interested in learning more about future opportunities can reach out to the Clever Carnivore team through https://clevercarnivore.com.

About Clever Carnivore

Clever Carnivore, founded and headquartered in Chicago, is a rapidly growing startup that uses cutting-edge biotechnology to bring low-cost, top-quality cultivated pork, beef and chicken to the consumer market. With Clever Carnivore’s high-efficiency model, cruelty-free, environmentally friendly and cost-competitive sausages, burgers and chicken nuggets will soon be a reality. For more information, visit https://clevercarnivore.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.